Aclaris Therapeutics, Inc. (ACRS)
3.52
+0.90
(+34.35%)
USD |
NASDAQ |
Jan 20, 11:25
Aclaris Therapeutics Total Liabilities (Quarterly): 55.43M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 191.70M |
| Puma Biotechnology, Inc. | 87.59M |
| Nephros, Inc. | 3.241M |
| Prelude Therapeutics, Inc. | 36.22M |
| Vivos Therapeutics, Inc. | 23.11M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 175.53M |
| Shareholders Equity (Quarterly) | 120.10M |
| Debt to Equity Ratio | 0.0187 |
| Current Ratio | 3.925 |
| Net Debt Paydown Yield | 0.06% |